Metraipolis › archive › dc_d7dff089cf35

Toxicities of CAR-T, Bispecific Antibodies, and Antibody-Drug Conjugates in Multiple Myeloma: A Practical Approach to Risk Mitigation and Management — Europe PMC PMID:42449627

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42449627
DOI
10.3390/cancers18132083
License (as archived)
solo-consultazione
Archived
2026-10-18T18:22:40.676Z
SHA-256 of the archived text
fe92a2b2b65b4986e06fc9148e53deef0083a673ee88310bfbf6fb609f0c5894
Stable URL of this page
https://metraipolis.com/documento/dc_d7dff089cf35

How to cite

Toxicities of CAR-T, Bispecific Antibodies, and Antibody-Drug Conjugates in Multiple Myeloma: A Practical Approach to Risk Mitigation and Management — Europe PMC PMID:42449627 — Europe PMC (en), https://europepmc.org/article/MED/42449627 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d7dff089cf35 (Metraipolis archive dc_d7dff089cf35, sha256 fe92a2b2b65b4986e06fc9148e53deef0083a673ee88310bfbf6fb609f0c5894)
BibTeX
@misc{dcd7dff089cf35,
  title = {Toxicities of CAR-T, Bispecific Antibodies, and Antibody-Drug Conjugates in Multiple Myeloma: A Practical Approach to Risk Mitigation and Management — Europe PMC PMID:42449627},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42449627},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d7dff089cf35; sha256 fe92a2b2b65b4986e06fc9148e53deef0083a673ee88310bfbf6fb609f0c5894},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42449627. Agents can read the archived copy with the MCP tool read_document.